LET’S GET TECHNICAL. Scientists from the biotech company Life Biosciences are investigating the safety and potential side ...
Morning Overview on MSN
The first cellular age-reversal therapy has been cleared for human trials
Life Biosciences has received FDA clearance to begin a first-in-human Phase 1 clinical trial of ER-100, a gene therapy ...
Today, more people are living past 100 than ever before — even though the maximum human lifespan hasn't moved past 115 years.
Blindness itself might become, at least in certain cases, partially reversible. This potential future stems from one of the ...
Plant regeneration represents a cornerstone of modern plant science, blending fundamental questions in developmental biology ...
Signal transduction and gene regulation are at the heart of cell and developmental biology, driving cell fate decisions and tissue homeostasis. In cancer, ...
With fresh focus on New Approach Methodologies (NAMs) to move away from animal models in biosciences and preclinical ...
Senator Chris Murphy delivers a blistering Senate floor address accusing President Trump of running a "24/7 corruption operation." In a speech titled "500 Days of Corruption," Murphy outlined ...
Russia’s Burevestnik cruise missile—codenamed "Skyfall" by NATO—represents a dramatic leap in nuclear weapons technology.
Sparkling Sciences Co., Ltd., under TOMO YUME Group, announced it has obtained international INCI certification for iPSC Exosome and completed Kyoto University's patent licensing agreement. INCI Name: ...
A groundbreaking human trial of ER-100, a cellular reprogramming therapy, has begun, testing whether damaged eye cells can be rejuvenated and potentially opening a new chapter in the science of aging.
Proprietary Synthetic Polynucleotide Platform Accelerates Non-Viral, Footprint-Free Induced Pluripotent Stem Cell Generation Amid Surging Commercialization of iPSC Therapies in JapanSEATTLE, June 16, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results